ProAssurance Merger with Doctors Co. Clears Key FTC Hurdle with Early Termination
PRA is trading near its 52-week low of $22.72 (5.5% above the low).
Summary
The Federal Trade Commission has granted early termination of the waiting period for ProAssurance's merger with The Doctors Company. This critical antitrust clearance significantly de-risks the transaction and accelerates its path to completion. The news follows an 8-K filed just minutes earlier, which broadly announced several new regulatory approvals for the pending merger. This specific FCT approval removes a major regulatory hurdle, bringing the deal closer to closing.
At the time of this announcement, PRA was trading at $23.98 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $22.72 to $24.85. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.